Literature DB >> 3465478

A study of the mechanism of selenite-induced hypomethylated DNA and differentiation of Friend erythroleukemic cells.

R Cox, S Goorha.   

Abstract

Sodium selenite is a good inducer of hemoglobin production in Friend erythroleukemic cells (FELC). At a concentration of 20 microM 70-80% of the cells produce hemoglobin and the DNA is hypomethylated. What is the mechanism for sodium selenite alteration of the DNA methylation pattern? Experiments with methionine adenosyltransferase (the enzyme that synthesizes adenosylmethionine) showed little effect of selenite on the activity of this enzyme in vitro or in vivo. Therefore, FELC are able to synthesize S-adenosylmethionine in the presence of sodium selenite. When sodium selenite was added to an in vitro assay for DNA methylase, the enzyme was non-competitively inhibited by 80% at 20 microM selenite with a Ki of 6 microM. DNA methylase isolated from control and selenite-treated FELC was purified through a DEAE-Sephacel column and no difference in activity was found. In the presence of selenite, DNA methylase is very sensitive to selenite inhibition, but removal of the selenite restores activity. However, DNA synthesized by FELC grown in the presence of selenite (no DNA methylase activity) was found to be hypomethylated. These results suggest that DNA methylase activity is inhibited in FELC grown in the presence of sodium selenite.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3465478     DOI: 10.1093/carcin/7.12.2015

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

Review 1.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

Review 2.  Epigenetics and lifestyle.

Authors:  Jorge Alejandro Alegría-Torres; Andrea Baccarelli; Valentina Bollati
Journal:  Epigenomics       Date:  2011-06       Impact factor: 4.778

Review 3.  Selenium and asthma.

Authors:  Robert L Norton; Peter R Hoffmann
Journal:  Mol Aspects Med       Date:  2011-10-15

4.  Both selenium deficiency and modest selenium supplementation lead to myocardial fibrosis in mice via effects on redox-methylation balance.

Authors:  Nicole Metes-Kosik; Ivan Luptak; Patricia M Dibello; Diane E Handy; Shiow-Shih Tang; Hui Zhi; Fuzhong Qin; Donald W Jacobsen; Joseph Loscalzo; Jacob Joseph
Journal:  Mol Nutr Food Res       Date:  2012-10-24       Impact factor: 5.914

5.  Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.

Authors:  Nong Xiang; Rui Zhao; Guoqing Song; Weixiong Zhong
Journal:  Carcinogenesis       Date:  2008-08-01       Impact factor: 4.944

6.  Selenite cataracts: activation of endoplasmic reticulum stress and loss of Nrf2/Keap1-dependent stress protection.

Authors:  Periyasamy Palsamy; Keshore R Bidasee; Toshimichi Shinohara
Journal:  Biochim Biophys Acta       Date:  2014-07-02

Review 7.  Selenium. Mechanistic aspects of anticarcinogenic action.

Authors:  G N Schrauzer
Journal:  Biol Trace Elem Res       Date:  1992 Apr-Jun       Impact factor: 3.738

Review 8.  Selenistasis: epistatic effects of selenium on cardiovascular phenotype.

Authors:  Jacob Joseph; Joseph Loscalzo
Journal:  Nutrients       Date:  2013-01-31       Impact factor: 5.717

9.  Associations of plasma selenium with arsenic and genomic methylation of leukocyte DNA in Bangladesh.

Authors:  J Richard Pilsner; Megan N Hall; Xinhua Liu; Habibul Ahsan; Vesna Ilievski; Vesna Slavkovich; Diane Levy; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble
Journal:  Environ Health Perspect       Date:  2011-01       Impact factor: 9.031

10.  Colorectal cancer cells Caco-2 and HCT116 resist epigenetic effects of isothiocyanates and selenium in vitro.

Authors:  Lawrence N Barrera; Ian T Johnson; Yongping Bao; Aedin Cassidy; Nigel J Belshaw
Journal:  Eur J Nutr       Date:  2012-08-26       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.